biokemix worldwide ltd
biokemix worldwide ltd Company Information
Company Number
09547901
Next Accounts
83 days late
Industry
Manufacture of pharmaceutical preparations
Manufacture of other chemical products n.e.c.
Shareholders
auric eusina ltd
transene company inc
View AllGroup Structure
View All
Contact
Registered Address
1 doughty street, london, WC1N 2PH
Website
https://biokemix.combiokemix worldwide ltd Estimated Valuation
Pomanda estimates the enterprise value of BIOKEMIX WORLDWIDE LTD at £69.7k based on a Turnover of £94k and 0.74x industry multiple (adjusted for size and gross margin).
biokemix worldwide ltd Estimated Valuation
Pomanda estimates the enterprise value of BIOKEMIX WORLDWIDE LTD at £201.8k based on an EBITDA of £45.9k and a 4.39x industry multiple (adjusted for size and gross margin).
biokemix worldwide ltd Estimated Valuation
Pomanda estimates the enterprise value of BIOKEMIX WORLDWIDE LTD at £193.4k based on Net Assets of £91.9k and 2.1x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biokemix Worldwide Ltd Overview
Biokemix Worldwide Ltd is a live company located in london, WC1N 2PH with a Companies House number of 09547901. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in April 2015, it's largest shareholder is auric eusina ltd with a 71.4% stake. Biokemix Worldwide Ltd is a young, micro sized company, Pomanda has estimated its turnover at £94k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biokemix Worldwide Ltd Health Check
Pomanda's financial health check has awarded Biokemix Worldwide Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £94k, make it smaller than the average company (£21.3m)
- Biokemix Worldwide Ltd
£21.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 2326%, show it is growing at a faster rate (3.4%)
- Biokemix Worldwide Ltd
3.4% - Industry AVG
Production
with a gross margin of 27.7%, this company has a comparable cost of product (27.7%)
- Biokemix Worldwide Ltd
27.7% - Industry AVG
Profitability
an operating margin of 48.9% make it more profitable than the average company (6.1%)
- Biokemix Worldwide Ltd
6.1% - Industry AVG
Employees
with 1 employees, this is below the industry average (58)
- Biokemix Worldwide Ltd
58 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Biokemix Worldwide Ltd
- - Industry AVG
Efficiency
resulting in sales per employee of £94k, this is less efficient (£522.7k)
- Biokemix Worldwide Ltd
£522.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Biokemix Worldwide Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 72 days, this is slower than average (37 days)
- Biokemix Worldwide Ltd
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Biokemix Worldwide Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (11 weeks)
0 weeks - Biokemix Worldwide Ltd
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94%, this is a higher level of debt than the average (44.4%)
94% - Biokemix Worldwide Ltd
44.4% - Industry AVG
BIOKEMIX WORLDWIDE LTD financials
Biokemix Worldwide Ltd's latest turnover from December 2022 is estimated at £94 thousand and the company has net assets of £91.9 thousand. According to their latest financial statements, we estimate that Biokemix Worldwide Ltd has 1 employee and maintains cash reserves of £951 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | 0 | 0 | 0 | |||||
| Number Of Employees | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 1,324,445 | 262,170 | 69,709 | 69,709 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,324,445 | 262,170 | 69,709 | 69,709 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Group Debtors | 204,838 | 162,686 | 370,970 | 200,296 | 0 | 0 | 0 | 0 |
| Misc Debtors | 1,300 | 814 | 739 | 0 | 0 | 0 | 0 | 0 |
| Cash | 951 | 21,127 | 67,563 | 96,207 | 0 | 0 | 1 | 1 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 207,089 | 184,627 | 439,272 | 296,503 | 1 | 1 | 1 | 1 |
| total assets | 1,531,534 | 446,797 | 508,981 | 366,212 | 1 | 1 | 1 | 1 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 13,530 | 10,930 | 1,830 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 354,286 | 235,782 | 228,950 | 86,692 | 0 | 0 | 0 | 0 |
| other short term finances | 15,714 | 21,157 | 92,531 | 122,973 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 30,342 | 38,274 | 13,527 | 6,968 | 0 | 0 | 0 | 0 |
| total current liabilities | 413,872 | 306,143 | 336,838 | 216,633 | 0 | 0 | 0 | 0 |
| loans | 1,025,736 | 44,460 | 45,000 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 1,025,736 | 44,460 | 45,000 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 1,439,608 | 350,603 | 381,838 | 216,633 | 0 | 0 | 0 | 0 |
| net assets | 91,926 | 96,194 | 127,143 | 149,579 | 1 | 1 | 1 | 1 |
| total shareholders funds | 91,926 | 96,194 | 127,143 | 149,579 | 1 | 1 | 1 | 1 |
| Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 42,638 | -208,209 | 371,708 | 200,295 | 0 | 1 | 0 | 0 |
| Creditors | 2,600 | 9,100 | 1,830 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | -7,932 | 24,747 | 13,527 | 6,968 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 1,062,275 | 192,461 | 69,709 | 69,709 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 118,504 | 6,832 | 228,950 | 86,692 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | -5,443 | -71,374 | 92,531 | 122,973 | 0 | 0 | 0 | 0 |
| Long term loans | 981,276 | -540 | 45,000 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | -20,176 | -46,436 | 67,563 | 96,207 | 0 | -1 | 0 | 1 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -20,176 | -46,436 | 67,563 | 96,207 | 0 | -1 | 0 | 1 |
biokemix worldwide ltd Credit Report and Business Information
Biokemix Worldwide Ltd Competitor Analysis
Perform a competitor analysis for biokemix worldwide ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in WC1N area or any other competitors across 12 key performance metrics.
biokemix worldwide ltd Ownership
BIOKEMIX WORLDWIDE LTD group structure
Biokemix Worldwide Ltd has no subsidiary companies.
Ultimate parent company
BIOKEMIX WORLDWIDE LTD
09547901
biokemix worldwide ltd directors
Biokemix Worldwide Ltd currently has 2 directors. The longest serving directors include Mr Sameer Bajaj (Jun 2019) and Mr Sameer Bajaj (Jun 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Sameer Bajaj | England | 54 years | Jun 2019 | - | Director |
| Mr Sameer Bajaj | England | 54 years | Jun 2019 | - | Director |
P&L
December 2022turnover
94k
+36%
operating profit
45.9k
0%
gross margin
27.7%
-4.08%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
91.9k
-0.04%
total assets
1.5m
+2.43%
cash
951
-0.95%
net assets
Total assets minus all liabilities
Similar Companies
biokemix worldwide ltd company details
company number
09547901
Type
Private limited with Share Capital
industry
46750 - Wholesale of chemical products
21200 - Manufacture of pharmaceutical preparations
20590 - Manufacture of other chemical products n.e.c.
incorporation date
April 2015
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2022
previous names
biokemix europe ltd (December 2017)
accountant
-
auditor
-
address
1 doughty street, london, WC1N 2PH
Bank
-
Legal Advisor
-
biokemix worldwide ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biokemix worldwide ltd.
biokemix worldwide ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOKEMIX WORLDWIDE LTD. This can take several minutes, an email will notify you when this has completed.
biokemix worldwide ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
